Limited sampling strategies for determining the area under the plasma concentration–time curve for isoniazid might be a valuable approach for optimizing treatment in adult patients with tuberculosis
Author:
Publisher
Elsevier BV
Subject
Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine
Reference29 articles.
1. The perpetual challenge of infectious diseases;Fauci;N Engl J Med,2012
2. Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: treatment of drug-susceptible tuberculosis;Nahid;Clin Infect Dis,2016
3. The case for using higher doses of first line anti-tuberculosis drugs to optimize efficacy;Goutelle;Curr Pharm Des,2014
4. Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatitis;Huang;Hepatology,2002
5. Hepatotoxicity associated with isoniazid preventive therapy: a 7-year survey from a public health tuberculosis clinic;Nolan;JAMA,1999
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Variability in plasma rifampicin concentrations and role of SLCO1B1 , ABCB1 , AADAC2 and CES2 genotypes in Ethiopian patients with tuberculosis;Infectious Diseases;2024-02-05
2. Correlation of N-acetyltransferase 2 genotype and acetylation status with plasma isoniazid concentration and its metabolic ratio in ethiopian tuberculosis patients;Scientific Reports;2023-07-15
3. Limited sampling strategies for therapeutic drug monitoring of anti-tuberculosis medications: A systematic review of their feasibility and clinical utility;Tuberculosis;2023-07
4. Influence of sex on the exposure to isoniazid in patients with pulmonary tuberculosis;Revista do Instituto de Medicina Tropical de São Paulo;2023
5. Population Pharmacokinetics and Pharmacodynamics of Isoniazid and its Metabolite Acetylisoniazid in Chinese Population;Frontiers in Pharmacology;2022-07-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3